FIELD: medicine, pharmacology. SUBSTANCE: invention proposes to use (adamant-2-yl)-(para-bromophenyl)-amine as an anxiolytic agent. Preparation combines anxiolytic and psychostimulating effect. EFFECT: enhanced effectiveness of agent, broadened spectrum of agents of indicated prescription. 1 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
1,4-BENZODIAZEPINE DERIVATIVES SHOWING SELECTIVE ANXIOLYTIC ACTIVITY | 1995 |
|
RU2133248C1 |
ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
PSYCHOSTIMULATING AGENT | 2003 |
|
RU2261709C2 |
ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
2-MERCAPTOBENZIMIDAZOLE DERIVATIVES HAVING SELECTIVE ANXIOLYTIC ACTIVITY | 1994 |
|
RU2061686C1 |
SUBSTITUTED 2-[2(3-OXOMORPHOLIN-4-YL)ETHYLTHIO]BENZIMIDAZOLES, WITH ANXIOLYTIC ACTIVITY | 2007 |
|
RU2373202C2 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
PHARMACEUTICAL COMPOSITION BASED ON LADASTEN | 2006 |
|
RU2376986C2 |
CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
1-ARYLPYRROLO[1,2A]PYRAZINE-3-CARBOXAMIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2572076C2 |
Authors
Dates
2001-10-27—Published
1999-12-22—Filed